Table 1 Effects of osilodrostat, metyrapone, and ketoconazole on the steroid profile in human adrenocortical cells
Table 2 Effects of osilodrostat, metyrapone, and ketoconazole on the steroid profile in two primary human adrenocortical cell cultures

Figure 1 Effects of osilodrostat, metyrapone, and ketoconazole on basal cortisol production in primary human adrenocortical carcinoma cultures
Figure 2 Effects of osilodrostat on cell amount and ACTH secretion corrected for cell amount in mouse pituitary AtT20 cells and in two primary human corticotroph pituitary adenoma cultures

Additional Metadata
Persistent URL hdl.handle.net/1765/115683
Journal Journal of Clinical Endocrinology and Metabolism
Note Manuscript nr: jc.2019-00217
Citation
Creemers, S.G. (2019). Supplementary material belonging to: Osilodrostat is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing’s Syndrome: an in Vitro Study. Journal of Clinical Endocrinology and Metabolism. Retrieved from http://hdl.handle.net/1765/115683